Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.

@article{PrezValderrama2016ValidationOT,
  title={Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.},
  author={Bego{\~n}a P{\'e}rez-Valderrama and Jose Angel Arranz Arija and Amparo Rodr{\'i}guez S{\'a}nchez and Alvaro Pinto Mar{\'i}n and P. Borrega Garc{\'i}a and D E Castellano Gaunas and G Rubio Romero and Constanza Maximiano Alonso and Jos{\'e} Carlos Villa Guzm{\'a}n and J L Puertas {\'A}lvarez and Isabel Chirivella Gonz{\'a}lez and M. J. M{\'e}ndez Vidal and Mar{\'i}a Jos{\'e} Juan Fita and Luis Le{\'o}n-Mateos and Mart{\'i}n L{\'a}zaro Quintela and R Garc{\'i}a Dom{\'i}nguez and Jos{\'e} Miguel Jurado Garc{\'i}a and E V{\'e}lez de Mendiz{\'a}bal and Julio Lambea Sorrosal and I Garc{\'i}a Carbonero and Ar{\'a}nzazu Gonz{\'a}lez del Alba and C Su{\'a}rez Rodr{\'i}guez and P Jim{\'e}nez Gallego and J A Meana Garc{\'i}a and R D Garc{\'i}a Marrero and Pablo Gajate Borau and C Santander Lobera and Carmen Molins Palau and Marta L{\'o}pez Brea and Eva Mar{\'i}a Fern{\'a}ndez Parra and O Reig Torras and Laura Basterretxea Badiola and Sergio V{\'a}zquez Est{\'e}vez and Jos{\'e} Luis Gonz{\'a}lez Larriba},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2016},
  volume={27 4},
  pages={706-11}
}
BACKGROUND Patients with metastatic renal carcinoma (mRCC) treated with first-line pazopanib were not included in the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model. SPAZO (NCT02282579) was a nation-wide retrospective observational study designed to assess the effectiveness and validate the IMDC prognostic model in patients treated with first-line pazopanib in clinical practice. PATIENTS AND METHODS Data of 278 patients, treated with first-line… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 11 times over the past 90 days. VIEW TWEETS
1 Citations
20 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 20 references

and Drug Administration

  • US Foo
  • Highlights of Prescribing Information. Votrient…
  • 2015

Similar Papers

Loading similar papers…